Dong Xiao-Yan, Wang Lan, Tao Yan-Xia, Suo Xiu-Li, Li Yue-Chuan, Liu Fang, Zhao Yue, Zhang Qing
School of Nursing, Tianjin Medical University.
Department of Respiratory Care, Tianjin Chest Hospital, Tianjin, People's Republic of China.
Int J Chron Obstruct Pulmon Dis. 2016 Dec 20;12:49-58. doi: 10.2147/COPD.S117626. eCollection 2017.
Anxiety is a common comorbidity in patients with COPD in China, and it can significantly decrease patients' quality of life. Almost all anxiety measurements contain somatic items that can overlap with symptoms of COPD and side effects of medicines, which can lead to bias in measuring anxiety in patients with COPD. Therefore, a brief and disease-specific non-somatic anxiety measurement scale, the Anxiety Inventory for Respiratory Disease (AIR), which has been developed and validated in its English version, is needed for patients with COPD in China.
A two-center study was conducted in two tertiary hospitals in Tianjin, China. A total of 181 outpatients with COPD (mean age 67.21±8.10 years, 32.6% women), who met the inclusion and exclusion criteria, were enrolled in the study. Test-retest reliability was examined using intraclass correlation coefficients. The internal consistency was calculated by Cronbach's . Content validity was examined using the Content Validity Index (CVI), scale-level CVI/universal agreement, and scale-level CVI/average agreement (S-CVI/Ave). Besides, convergent validity and construct validity were also examined.
The AIR-C (AIR-Chinese version) scale had high test-retest reliability (intraclass correlation coefficient =0.904) and internal consistency (Cronbach's =0.914); the content validity of the AIR-C scale was calculated by CVI, scale-level CVI/universal agreement, and S-CVI/Ave at values of 0.89-1, 0.90, and 0.98, respectively. Meanwhile, the AIR-C scale had good convergent validity, correlating with the Hospital Anxiety and Depression Scale-Anxiety (=0.81, <0.01), and there were significant correlations between the AIR-C and Clinical COPD Questionnaire (CCQ; =0.44, <0.01) and Activities of Daily Living Scale (ADLS; =0.36, <0.01). A two-factor model of general anxiety and panic symptoms in the AIR-C scale had the best fit according to Confirmatory Factor Analysis (CFA).
The AIR-C scale had a good reliability and validity for patients with COPD and can be used as a user-friendly and valid tool for measuring anxiety symptoms among patients with COPD in China.
在中国,焦虑是慢性阻塞性肺疾病(COPD)患者中常见的共病情况,它会显著降低患者的生活质量。几乎所有的焦虑测量都包含躯体项目,这些项目可能与COPD症状及药物副作用重叠,从而导致在测量COPD患者的焦虑时产生偏差。因此,中国的COPD患者需要一个简短且针对该疾病的非躯体性焦虑测量量表,即呼吸疾病焦虑量表(AIR),其英文版本已开发并验证。
在中国天津的两家三级医院进行了一项双中心研究。共有181名符合纳入和排除标准的COPD门诊患者(平均年龄67.21±8.10岁,女性占32.6%)参与了该研究。使用组内相关系数检验重测信度。通过克朗巴哈系数计算内部一致性。使用内容效度指数(CVI)、量表水平CVI/普遍一致性和量表水平CVI/平均一致性(S-CVI/Ave)检验内容效度。此外,还检验了收敛效度和结构效度。
AIR-C(AIR中文版)量表具有较高的重测信度(组内相关系数=0.904)和内部一致性(克朗巴哈系数=0.914);AIR-C量表的内容效度通过CVI、量表水平CVI/普遍一致性和S-CVI/Ave计算,分别为0.89 - 1、0.90和0.98。同时,AIR-C量表具有良好的收敛效度,与医院焦虑抑郁量表-焦虑分量表相关(=0.81,<0.01),并且AIR-C与临床COPD问卷(CCQ;=0.44,<0.01)和日常生活活动量表(ADLS;=0.36,<0.01)之间存在显著相关性。根据验证性因子分析(CFA),AIR-C量表中一般焦虑和惊恐症状的双因素模型拟合度最佳。
AIR-C量表对COPD患者具有良好的信度和效度,可作为在中国测量COPD患者焦虑症状的一种方便且有效的工具。